Clinical outcomes of nirmatrelvir-ritonavir use in pregnant women during the Omicron wave of the coronavirus disease 2019 pandemic

• मुख्य लेखकों: Chih-Wei Lin (लेखक), Yu-Ling Liang (लेखक), Ming-Ta Chuang (लेखक), Chun-Han Tseng (लेखक), Pei-Yin Tsai (लेखक), Mei-Tsz Su (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: Elsevier, 2023-12-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

Background: Paxlovid is an oral drug composed of nirmatrelvir and ritonavir that has been demonstrated to be effective in decreasing the risk of severe coronavirus disease 2019 (COVID-19). Here, we report the use of paxlovid in pregnant women with COVID-19. Methods: Pregnant women attending a tertia...